Med24
Clinical Medicine 21. 10. 2026 • 2 min read • MedPage Today

Study Supports Starting HPV Vaccination at a Younger Age

WASHINGTON -- Children who started the two-dose human papillomavirus (HPV) vaccine series at age 9 or 10 years were more than twice as likely to get both shots versus those who began later, a cluster randomized trial showed...

Study Supports Starting HPV Vaccination at a Younger Age

A cluster randomized trial across 31 U.S. pediatric practices demonstrated that children who started the human papillomavirus (HPV) vaccine series at age 9 or 10 years were more likely to receive both shots compared to those who began later. This research involved 62,271 children and adolescents aged 9 to 13 years, with nearly half being female and approximately 22% on Medicaid.

Study Results and Demographics

Initiation rates were 77.1% for those starting at 9 or 10 years, compared to 67% for those starting at 11 or 12 years. Completion rates were 61.6% for the earlier start group versus 45.1% for the later start group. Median age at vaccination initiation was 11.0 years in the early-start clinics compared with 11.8 years in the standard-start clinics, while median age at vaccination completion was 12.2 years and 13.3 years, respectively. Parental hesitancy and acceptance didn’t differ significantly between the groups. The main pushback in the early-start clinics stemmed from parents who hadn’t realized a shot would occur at the well visit.

Sponsored content

Clinical Recommendations and CDC Guidance

Clinicians who started at 11 or older were suggested to consider earlier introduction in their offices. Key vaccination guidelines suggest that an earlier start to HPV vaccination is possible, and previous research has shown that a head start can be effective. The **CDC** recommends HPV vaccination for children at ages 11 or 12 years, though the agency notes that vaccination can start at age 9. The American Academy of Pediatrics recommends starting the vaccine series between 9 and 12 years, at an age that the provider deems optimal for acceptance and completion of the vaccination series. Getting an earlier start at age 9 didn’t affect receipt of other vaccines or later well-child visits, nor did rates of meningococcal or tetanus, diphtheria, and pertussis (Tdap) vaccination by age 13. Research shows that vaccination at younger ages still leads to longer-term protection. “What we’ve seen is there doesn’t appear to be any waning of protection.”

Original Scientific Source
MedPage Today
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement